{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:14:23Z","timestamp":1760980463012},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1977,12,1]],"date-time":"1977-12-01T00:00:00Z","timestamp":249782400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neural Transmission"],"published-print":{"date-parts":[[1977,12]]},"DOI":"10.1007\/bf01252019","type":"journal-article","created":{"date-parts":[[2005,3,23]],"date-time":"2005-03-23T14:50:53Z","timestamp":1111589453000},"page":"241-251","source":"Crossref","is-referenced-by-count":65,"title":["Brain-noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's syndrome"],"prefix":"10.1007","volume":"41","author":[{"given":"P.","family":"Riederer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Birkmayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Seemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St.","family":"Wuketich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.2042-7158.1970.tb10584.x","volume":"22","author":"C. V. Atack","year":"1970","unstructured":"Atack, C. V., Magnusson, T. Individual elution of noradrenaline (together with adrenaline), dopamine, 5-hydroxytryptamine and histamine from a single, strong cation exchange column, by means of mineral acid-organic solvent mixtures. J. Pharm. Pharmacol.22, 625?627 (1970).","journal-title":"J. Pharm. Pharmacol."},{"key":"CR2","first-page":"347","volume-title":"Advances in Neurology, Vol. 5","author":"A. Barbeau","year":"1974","unstructured":"Barbeau, A. The clinical physiology of side effects in long-term L-DOPA therapy. In: Advances in Neurology, Vol. 5 (McDowell, F. H., Barbeau, A., eds.), p. 347. New York: Raven Press. 1974."},{"key":"CR3","first-page":"558","volume":"74","author":"H. Bernheimer","year":"1962","unstructured":"Bernheimer, H., Birkmayer, W., Hornykiewicz, O. Verhalten der Monoaminooxydase im Gehirn des Menschen nach Therapie mit Monoaminooxydasehemmern. Wien. klin. Wschr.74, 558?559 (1962).","journal-title":"Wien. klin. Wschr."},{"key":"CR4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","volume":"20","author":"H. Bernheimer","year":"1973","unstructured":"Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K., Seitelberger, F. Brain dopamine and the syndromes of Parkinson and Huntington. J. neurol. Sciences20, 415?455 (1973).","journal-title":"J. neurol. Sciences"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1748-1716.1958.tb01627.x","volume":"44","author":"A. Bertler","year":"1958","unstructured":"Bertler, A., Carlsson, A., Rosengren, E. A method for the fluorometric determination of adrenaline and noradrenaline in tissues. Acta Physiol. Scand.44, 273?292 (1958).","journal-title":"Acta Physiol. Scand."},{"key":"CR6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF01260902","volume":"33","author":"W. Birkmayer","year":"1972","unstructured":"Birkmayer, W., Danielczyk, W., Neumayer, E., Riederer, P. The balance of biogenic amines as condition for normal behaviour. J. Neural Transm.33, 163?178 (1972).","journal-title":"J. Neural Transm."},{"key":"CR7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF01250738","volume":"35","author":"W. Birkmayer","year":"1974","unstructured":"Birkmayer, W., Danielczyk, W., Neumayer, E., Riederer, P. Nucleus ruber and L-DOPA psychosis: biochemical post mortem findings. J. Neural Transm.35, 93?116 (1974).","journal-title":"J. Neural Transm."},{"key":"CR8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF01253131","volume":"36","author":"W. Birkmayer","year":"1975","unstructured":"Birkmayer, W., Riederer, P., Youdim, M. B. H., Linauer, W. The potentiation of the anti-akinetic effect after L-DOPA treatment by an inhibitor of MAO-B, Deprenil. J. Neural Transm.36, 303?326 (1975).","journal-title":"J. Neural Transm."},{"key":"CR9","first-page":"141","volume-title":"Psychobiology of the Striatum","author":"W. Birkmayer","year":"1977","unstructured":"Birkmayer, W., Jellinger, K., Riederer, P. Striatal and extrastriatal dopaminergic functions. In: Psychobiology of the Striatum (Cools, A. R., Lohman, A. H. M., vanden Bercken, J. H. L., eds.), pp. 141?153. Amsterdam-New York-Oxford: North-Holland. 1977."},{"key":"CR10","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1073\/pnas.68.3.662","volume":"68","author":"J. P. Chalmers","year":"1971","unstructured":"Chalmers, J. P., Baldessarini, R. J., Wurtman, R. J. Effects of L-DOPA on brain norepinephrine metabolism. Proc. nat. Acad. Sci. (Wash.)68, 662 (1971).","journal-title":"Proc. nat. Acad. Sci. (Wash.)"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1471-4159.1973.tb06003.x","volume":"21","author":"T. N. Chase","year":"1973","unstructured":"Chase, T. N., Gordon, E. K., Ng, L. K. Y. Norepinephrine metabolism in the central nervous system of man: studies using 3-methoxy-4-hydroxy-phenylethylene glycol levels in cerebrospinal fluid. J. Neurochem.21, 581?587 (1973).","journal-title":"J. Neurochem."},{"key":"CR12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1471-4159.1972.tb01354.x","volume":"19","author":"J. T. Coyle","year":"1972","unstructured":"Coyle, J. T., Axelrod, J. Dopamine-?-hydroxylase in the rat brain: development characteristics. J. Neurochem.19, 449?459 (1972).","journal-title":"J. Neurochem."},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1236 to 1239","DOI":"10.1007\/BF01485901","volume":"38","author":"H. Ehringer","year":"1960","unstructured":"Ehringer, H., Hornykiewicz, O. Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Klin. Wschr.38, 1236 to 1239 (1960).","journal-title":"Klin. Wschr."},{"key":"CR14","first-page":"178","volume-title":"Advances in Parkinsonism","author":"I. J. Farley","year":"1976","unstructured":"Farley, I. J., Hornykiewicz, O. Noradrenaline in subcortical brain regions of patients with Parkinson's disease and control subjects. In: Advances in Parkinsonism (Birkmayer, W., Hornykiewicz, O., eds.), pp. 178?185. Basle: Editiones ?Roche?. 1976."},{"key":"CR15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0009-8981(75)90039-X","volume":"59","author":"L. Fellows","year":"1975","unstructured":"Fellows, L., Riederer, P., Sandler, M. A rapid assay of 4-hydroxy-3-methoxyphenylglycol in urine. Clin. Chim. Acta59, 255?257 (1975).","journal-title":"Clin. Chim. Acta"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0079-6123(08)63959-X","volume":"34","author":"K. Fuxe","year":"1971","unstructured":"Fuxe, K., Goldstein, M., H\u00f6kfelt, T., Joh, T. H. Cellular localization of dopamine-?-hydroxylase and phenylethanolamine-N-methyl transferase as revealed by immunohistochemistry. Prog. Brain Res.34, 127?138 (1971).","journal-title":"Prog. Brain Res."},{"key":"CR17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1152\/physrev.1971.51.1.98","volume":"51","author":"L. B. Geffen","year":"1971","unstructured":"Geffen, L. B., Livett, B. G. Synaptic vesicles in sympathetic neurons. Physiol. Rev.51, 98?157 (1971).","journal-title":"Physiol. Rev."},{"key":"CR18","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/21.4.312","volume":"21","author":"B. K. Hartman","year":"1972","unstructured":"Hartman, B. K. Immunofluorescence of dopamine-?-hydroxylase. Application of improved methodology to the localization of the peripheral and central noradrenergic nervous system. J. Histochem. Cytochem.21, 312?332 (1972).","journal-title":"J. Histochem. Cytochem."},{"key":"CR19","first-page":"309 to 312","volume":"75","author":"O. Hornykiewicz","year":"1963","unstructured":"Hornykiewicz, O. Die topische Lokalisation und das Verhalten von Noradrenalin und Dopamin (3-Hydroxytyramin) in der Substantia nigra des normalen und parkinsonkranken Menschen. Wien. klin. Wschr.75, 309 to 312 (1963).","journal-title":"Wien. klin. Wschr."},{"key":"CR20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1471-4159.1976.tb01539.x","volume":"27","author":"F. Karoum","year":"1976","unstructured":"Karoum, F., Neff, N. H., Wyatt, R. J. Distribution and turnover rate of vanillylmandelic acid and 3-methoxy-4-hydroxyphenylglycol in rat brain. J. Neurochem.27, 33?35 (1976).","journal-title":"J. Neurochem."},{"key":"CR21","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.2042-7158.1974.tb10683.x","volume":"26","author":"H. H. Keller","year":"1974","unstructured":"Keller, H. H., Bartholini, G., Pletscher, A. Enhancement of noradrenaline turnover in rat brain by L-DOPA. J. Pharm. Pharmacol.26, 649 (1974).","journal-title":"J. Pharm. Pharmacol."},{"issue":"3","key":"CR22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1212\/WNL.25.3.223","volume":"25","author":"R. M. Kobayashi","year":"1975","unstructured":"Kobayashi, R. M., Palkovits, M., Jacobowitz, D. M., Kopin, I. J. Biochemical mapping of the noradrenergic projection from the locus coeruleus. Neurology25 (3), 223?233 (1975).","journal-title":"Neurology"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0140-6736(72)90725-8","volume":"i","author":"A. N. Lieberman","year":"1972","unstructured":"Lieberman, A. N., Freedman, L. S., Goldstein, M. Serum dopamine-?-hydroxylase activity in patients with Huntington's chorea and Parkinson's disease. Lanceti, 153?154 (1972).","journal-title":"Lancet"},{"key":"CR24","first-page":"173","volume-title":"Advances in Neurology, Vol. 3","author":"K. G. Lloyd","year":"1973","unstructured":"Lloyd, K. G., Davidson, L., Hornykiewicz, O. Metabolism of levodopa in the human brain. In: Advances in Neurology, Vol. 3, pp. 173?188. New York: Raven Press. 1973."},{"key":"CR25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF01250277","volume":"40","author":"E. S. Markianos","year":"1977","unstructured":"Markianos, E. S., R\u00fcther, E. Serum dopamine-?-hydroxylase in parkinsonism. J. Neural Transm.40, 21?25 (1977).","journal-title":"J. Neural Transm."},{"key":"CR26","unstructured":"Redmond, D. E., Huang, Y. H., Snyder, D. R., Maas, J. W., Baulu, J.: Behavioral changes following lesions of the locus coeruleus in macaca arctiodes. Neuroscience Abstracts, Vol. II, Part I and Part II (1976)."},{"key":"CR27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1471-4159.1972.tb01269.x","volume":"19","author":"D. J. Reis","year":"1972","unstructured":"Reis, D. J., Molinoff, P. B. Brain dopamine-?-hydroxylase: Regional distribution and effects of lesions and 6-hydroxydopamine on activity. J. Neurochem.19, 195?204 (1972).","journal-title":"J. Neurochem."},{"key":"CR28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF01249445","volume":"38","author":"P. Riederer","year":"1976","unstructured":"Riederer, P., Wuketich, St. Time course of nigrostriatal degeneration in Parkinson's disease. J. Neural Transm.38, 277?301 (1976).","journal-title":"J. Neural Transm."},{"issue":"3","key":"CR29","first-page":"292","volume":"358","author":"P. Riederer","year":"1977","unstructured":"Riederer, P. The distribution of free 4-hydroxy-3-methoxyphenylglycol in post mortem brains of Parkinsonian and depressed patients. Hoppe-Seyler's Z. Physiol. Chem.358 (3), 292?293 (1977).","journal-title":"Hoppe-Seyler's Z. Physiol. Chem."},{"key":"CR30","unstructured":"Riederer, P., Wuketich, St.: Quantitative dissection of human basal ganglia, nucleus ruber and nucleus amygdalae and absolute values of biogenic amines in Parkinson's disease and Huntington's Chorea. Acta Neuropath. (Berl.), in press (1977)."},{"key":"CR31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/archneur.1973.00490200055007","volume":"28","author":"U. K. Rinne","year":"1973","unstructured":"Rinne, U. K., Sonninen, V. Brain catecholamines and their metabolites in Parkinsonian patients. Arch. Neurol. (Chic.)28, 107?110 (1973).","journal-title":"Arch. Neurol. (Chic.)"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF01266304","volume":"39","author":"C. G. Swahn","year":"1976","unstructured":"Swahn, C. G., Wiesel, F. A. Determination of conjugated monoamine metabolites in brain tissue. J. Neural Transm.39, 281?290 (1976).","journal-title":"J. Neural Transm."}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01252019.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01252019\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01252019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T10:48:03Z","timestamp":1556794083000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01252019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1977,12]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1977,12]]}},"alternative-id":["BF01252019"],"URL":"https:\/\/doi.org\/10.1007\/bf01252019","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[1977,12]]}}}